NAMPT and metabolic dysfunction-associated steatohepatitis: However, some studies also verified the augmented levels of serum visfatin in NAFLD compared to controls [113] or the decreased visfatin levels in NAFLD [114], SS, or NASH patients versus controls [86,111].